What Is Persistent Depressive Disorder?

  • 1st Revision: Holly Morgan

Get health & wellness advice into your inbox

Your privacy is important to us. Any information you provide to us via this website may be placed by us on servers. If you do not agree to these placements, please do not provide the information.

Best Milk Alternative

Overview

In a world with an increasing incidence of mental health disorders, increasing awareness and research on mental health has become essential. 

Depression, a mood disorder, is one of the most common mental health disorders and the leading cause of disability1 and suicide deaths worldwide.2 Persistent depressive disorder (PDD), sometimes referred to as dysthymia, is a form of depression characterised by its long duration. With a prevalence of around 12%, PPD has a huge impact on our society.3 Increasing awareness of this disorder is essential so that sufferers can understand what they are going through, get the help they need and know that they’re not alone. Even though there are both psychological and pharmacological treatments available, further research is needed, mainly because antidepressants canhave many side effects and are not very effective in many cases. 

This article will explore what persistent depressive disorder is by talking about aspects such as its causes, symptoms, treatment and diagnosis.

Causes of persistent depressive disorder

The exact cause of persistent depressive disorder (PDD) remains unknown. However, its development seems to usually be linked to one or more of physiological, genetic, environmental, or psychological factors:

Biological differences

The development of PDD is often associated with physical changes that affect the brain such as:

  • Brain anatomy - wasting of the prefrontal cortex (part of the brain that regulates are thoughts, actions and emotions)
  • Brain chemistry - Decrease in the concentration of serotonin - chemical that carries messages between brain and rest of body andplatelet monoamine oxidase - enzyme that breaks down amines in the brain
  • Dysregulation of the immune system
  • euroendocrine abnormalities - Changes to hormones in brain such as the increase in cortisol concentration.4 This hormone, which is also referred to as the stress hormone, can lead to other changes such as neuronal death in the hippocampus5

Genetic factors

Those with a family history of PDD are more likely to suffer from the disorder. 

Psychological and environmental factors

 Traumatic events (e.g. sexual or emotional abuse) and chronic stress can lead to PDD6

Signs and symptoms of persistent depressive disorder

PDD is associated with different signs and symptoms and knowing these can facilitate people suffering from this disorder to get the help they need. Depressive symptoms include:7

  • Depressed mood
  • Reduced or increased appetite
  • Difficulty falling asleep (insomnia) or sleeping too much (hypersomnia)
  • Lack of energy or fatigue
  • Low self-esteem 
  • Indecisiveness and poor concentration
  • Pessimism and feeling of hopelessness

Management and treatment for persistent depressive disorder

The primary treatment strategy for PDD consists of using antidepressants and psychotherapies alone or in combination. These treatments have been shown to be less effective in chronic forms of depression (dysthymic disorder) than in non-chronic ones. T Symptoms of around 40% of patients suffering from PDD are considered to be treatment resistant.4

Psychotherapy

One of the most effective current treatments used is Cognitive Behavioural Therapy (CBT). This talk therapy is based on improving the patient’s knowledge and awareness of PDD, so that they can understand what they are going through, and on helping patients to identify and deal with what is making them feel depressed.8

Drug-based depression treatments

Fortunately, some PDD patients do respond satisfactorily to their pharmacological treatments. Specifically, antidepressant medications such as selective serotonin reuptake inhibitors (SSRIs) and the antipsychotic amisulpride have shown to be relatively efficacious for treating PDD. The SSRI fluoxetine may be less effective than other drugs.4

Diagnosis

If a doctor suspects that a patient might be suffering from dysthymia, they may carry some tests out such as lab tests and physical exams in order to ensure that the symptoms are not being caused by an underlying physical health condition (e.g. hypothyroidism). 

Patients may be referred to mental health professionals for  a full evaluation where they may be askedabout their thoughts, feelings, and behaviour to determine whether they are suffering from PDD.

In the USmental health professionals use the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) from the American Psychiatric Association. This manual establishes that, to be diagnosed with PDD, the patient must have a depressed mood for at least 2 years. Children and adolescents may present with a irritable mood and 1 year is enough to be diagnosed. Symptoms cannot be absent for more than 2 months and at least two of the symptoms characteristic of PDD must be present.3

Risk factors

Risk factors that can contribute to the development of a persistent depression include:9

  • Family history: Although no specific genes have been linked yet to the development of PDD, it is known that genetic factors are involved. Having a family history of PDD puts aperson more at risk for developing the condition. Having a family history of other mental health conditions can also be a risk factor for developing PDD
  • Trauma or stress: Traumatic life events and excessive stress can also increase the likelihood of developing PDD
  • Depressive personality: Personality traits such as negativity, low self-esteem, high self-criticism and being too dependent are associated with developing PDD
  • Low social support: Having a low social support together with interpersonal difficulties can increase the risk of developing a mental health disorder such as PDD
  • Substance abuse disorder: Substance misuse increases the risk of suffering from PDD. In fact, approximately 21% of people with a substance abuse disorder also suffer from depression.10 However, substance misuse can both make people more likely to suffer from PDD and be a complication linked to PDD 
  • Physical illness: People suffering from health conditions such as cardiovascular disease, cancer, and diabetes are more likely to suffer from depression as they might have difficulties linked to the management of their condition. For instance, people with diabetes are twice as likely to suffer from depression, and may thus lead to a person developing PDD11
  • Gender: Females are twice likely to suffer from PDD than males

Complications

The complications that can derive from untreated PDD are similar to those of other mental health disorders. These include:

  • Suicidal ideation and behaviour: The main complication that can derive from PDD is suicidal thought and self-harm
  • Personal problems: PDD can lead to relationship difficulties, family conflicts and school or work problems due to the difficulty that patients have to get things done and their poor concentration
  • Substance misuse: Substance abuse disorder can be considered to be a complication of PDD aswell as a risk factor
  • Health problems: PDD itself can lead to the development of other mental health disorders (e.g. personality disorders and bipolar disorder) and can also affect physical health (e.g. heart disease due to the increased heart rate, blood pressure, and cortisol levels characteristic of depression)12
  • FAQs

How can I prevent persistent depressive disorder?

There is no clear way of preventing PDD. However, there are some strategies that might help to prevent its symptoms. These include, being physically active, having a healthy diet,13 controlling stress, trying to boost your self-esteem and being close to your family and friends. To prevent a relapse of symptoms once you have suffered from PDD, consider getting a long-term treatment plan.

How common is persistent depressive disorder?

In the UK, the prevalence of mild depression is 11.3% whilst severe depressive symptoms is 3.3%.14 For PDD specifically, it has been suggested that the prevalence for PDD with chronic major depressive disorder is 15.2% and the prevalence for PDD with pure dysthymia is 3.3%.3

When should I see a doctor?

If you have some of the characteristics of PDD, you should make an appointment with either your doctor or a mental health professional, as having an early diagnosis can be crucial. If you are having a depressive episode and either feel you might hurt yourself or are having suicidal thoughts, call your local emergency number as soon as possible.

Summary

PDD is a form of depression characterised by the long duration of its symptoms, which in adults must last longer than 2 years in order to be diagnosed. The development of PDD might be linked to biological, psychological, environmental and genetic factors. Its symptoms can be really challenging, which is one of the reasons why PDD, as well as other forms of depression, is associated with a high risk of self-harm and suicidal ideation. Symptoms include depressed mood, changes in appetite and sleep, fatigue, low self-esteem and feeling of hopelessness. Treatment of PDD is based on the use of pharmacotherapy and/or psychotherapy. However, further research is needed due to the low effectiveness, side effects and resistance to treatments that occurs in some cases. At the same time, it is also importantto increase awareness of PDD so that both people suffering from it and the people around them understand how to act.

References

  1. WHO. Depressive disorder (depression) [Internet]. World Health Organization. 2023 [cited 2023 May 28]. Available from: https://www.who.int/news-room/fact-sheets/detail/depression
  2. Bachmann S. Epidemiology of suicide and the psychiatric perspective. International journal of environmental research and public health. 2018 Jul;15(7):1425.
  3. Patel RK, Rose GM. Persistent Depressive Disorder [Internet]. StatPearls Publishing. 2021 [cited 2023 May 28] Available from: https://www.ncbi.nlm.nih.gov/books/NBK541052/
  4. Schramm E, Klein DN, Elsaesser M, Furukawa TA, Domschke K. Review of dysthymia and persistent depressive disorder: history, correlates, and clinical implications. The Lancet Psychiatry. 2020 Sep 1;7(9):801-12.
  5. McEwen BS, Nasca C, Gray JD. Stress effects on neuronal structure: hippocampus, amygdala, and prefrontal cortex. Neuropsychopharmacology. 2016 Jan;41(1):3-23.
  6. Negele A, Kaufhold J, Kallenbach L, Leuzinger-Bohleber M. Childhood trauma and its relation to chronic depression in adulthood. Depression research and treatment. 2015 Oct;2015.
  7. Sansone RA, Sansone LA. Dysthymic disorder: forlorn and overlooked?. Psychiatry (Edgmont). 2009 May 1;6(5):46.
  8. Gautam M, Tripathi A, Deshmukh D, Gaur M. Cognitive behavioral therapy for depression. Indian journal of psychiatry. 2020 Jan;62(Suppl 2):S223.
  9. Chen KH, Tam CW, Chang K. Early maladaptive schemas, depression severity, and risk factors for persistent depressive disorder: A cross-sectional study. East Asian Archives of Psychiatry. 2019 Dec;29(4):112-7.
  10. NAMI. Depression [Internet]. National Alliance on Mental Illness. 2017 [cited 2023 May 29]. Available from: https://www.nami.org/About-Mental-Illness/Mental-Health-Conditions/Depression
  11. DiabetesUK. Depression and diabetes [Internet]. Diabetes UK. n.d. [cited 2023 May 30]. Available from: https://www.diabetes.org.uk/guide-to-diabetes/emotions/depression
  12. American Heart Association. How does depression affect the heart [Internet]. American Heart Association. 2021 [cited 2023 May 30]. Available from: https://www.heart.org/en/healthy-living/healthy-lifestyle/mental-health-and-wellbeing/how-does-depression-affect-the-heart
  13. Jacka FN, Berk M. Depression, diet and exercise. The Medical Journal of Australia. 2013 Oct 29;199(6):S21-3.
  14. de la Torre JA, Vilagut G, Ronaldson A, Dregan A, Ricci-Cabello I, Hatch SL, Serrano-Blanco A, Valderas JM, Hotopf M, Alonso J. Prevalence and age patterns of depression in the United Kingdom. A population-based study. Journal of Affective Disorders. 2021 Jan 15;279:164-72.

Get health & wellness advice into your inbox

Your privacy is important to us. Any information you provide to us via this website may be placed by us on servers. If you do not agree to these placements, please do not provide the information.

Best Milk Alternative
[optin-monster-inline slug="yw0fgpzdy6fjeb0bbekx"]
This content is purely informational and isn’t medical guidance. It shouldn’t replace professional medical counsel. Always consult your physician regarding treatment risks and benefits. See our editorial standards for more details.

Get our health newsletter

Get daily health and wellness advice from our medical team.
Your privacy is important to us. Any information you provide to this website may be placed by us on our servers. If you do not agree do not provide the information.

Susana Nuevo Bonastre

Bachelor of Pharmacology – BSc, University of Manchester

Susana is a pharmacologist with strong organizational and communication skills and a special interest in medical writing. For her final year at the University of Manchester, she did a project in science communication, for which she developed an e-learning resource to increase awareness of Major Depressive Disorder. Susana is currently finishing a taught Master’s in neuroscience and psychology of mental health at King’s College. Susana has experience as a mentor and as a medical writer at Klarity Health and, even though she is specially interested in mental health and psychopharmacology, she has also written articles related to nutrition and different diseases.

Leave a Reply

Your email address will not be published. Required fields are marked *

my.klarity.health presents all health information in line with our terms and conditions. It is essential to understand that the medical information available on our platform is not intended to substitute the relationship between a patient and their physician or doctor, as well as any medical guidance they offer. Always consult with a healthcare professional before making any decisions based on the information found on our website.
Klarity is a citizen-centric health data management platform that enables citizens to securely access, control and share their own health data. Klarity Health Library aims to provide clear and evidence-based health and wellness related informative articles. 
Email:
Klarity / Managed Self Ltd
Alum House
5 Alum Chine Road
Westbourne Bournemouth BH4 8DT
VAT Number: 362 5758 74
Company Number: 10696687

Phone Number:

 +44 20 3239 9818